Vindesine

Vindesine

Clinical data
AHFS/Drugs.com	Micromedex Detailed Consumer Information
Pregnancy category	AU: D
Routes of administration	Intravenous
ATC code	L01CA03 (WHO)
Legal status
Legal status	In general: ℞ (Prescription only)
Pharmacokinetic data
Protein binding	65-75%
Metabolism	Hepatic (CYP3A4-mediated)
Elimination half-life	24 hours
Excretion	Biliary and renal
Identifiers
IUPAC name methyl (5S,7S,9S)- 9-[(2β,3β,4β,5α,12β,19α)- 3-(aminocarbonyl)- 3,4-dihydroxy- 16-methoxy- 1-methyl- 6,7-didehydroaspidospermidin- 15-yl]- 5-ethyl- 5-hydroxy- 1,4,5,6,7,8,9,10-octahydro- 2H- 3,7-methanoazacycloundecino[5,4-b]indole- 9-carboxylate
CAS Number	59917-39-4 Y
PubChem CID	40839
DrugBank	DB00309 Y
ChemSpider	37302 Y
UNII	RSA8KO39WH
KEGG	D01769 Y
ChEBI	CHEBI:36373 Y
ChEMBL	ChEMBL219146 Y
E number	{{#property:P628}}
ECHA InfoCard	{{#property:P2566}}
Chemical and physical data
Formula	C43H55N5O7
Molar mass	753.926 g/mol
3D model (JSmol)	Interactive image
SMILES O=C(OC)[C@]4(c2c(c1ccccc1n2)CCN3C[C@](O)(CC)C[C@@H](C3)C4)c5c(OC)cc6c(c5)[C@@]89[C@@H](N6C)[C@@](O)(C(=O)N)[C@H](O)[C@@]7(/C=C\CN([C@@H]78)CC9)CC
InChI InChI=1S/C43H55N5O7/c1-6-39(52)21-25-22-42(38(51)55-5,33-27(13-17-47(23-25)24-39)26-11-8-9-12-30(26)45-33)29-19-28-31(20-32(29)54-4)46(3)35-41(28)15-18-48-16-10-14-40(7-2,34(41)48)36(49)43(35,53)37(44)50/h8-12,14,19-20,25,34-36,45,49,52-53H,6-7,13,15-18,21-24H2,1-5H3,(H2,44,50)/t25-,34+,35-,36-,39+,40-,41-,42+,43+/m1/s1 Y Key:HHJUWIANJFBDHT-KOTLKJBCSA-N Y
(verify)

WikiDoc Resources for Vindesine
Articles
Most recent articles on Vindesine Most cited articles on Vindesine Review articles on Vindesine Articles on Vindesine in N Eng J Med, Lancet, BMJ
Media
Powerpoint slides on Vindesine Images of Vindesine Photos of Vindesine Podcasts & MP3s on Vindesine Videos on Vindesine
Evidence Based Medicine
Cochrane Collaboration on Vindesine Bandolier on Vindesine TRIP on Vindesine
Clinical Trials
Ongoing Trials on Vindesine at Clinical Trials.gov Trial results on Vindesine Clinical Trials on Vindesine at Google
Guidelines / Policies / Govt
US National Guidelines Clearinghouse on Vindesine NICE Guidance on Vindesine NHS PRODIGY Guidance FDA on Vindesine CDC on Vindesine
Books
Books on Vindesine
News
Vindesine in the news Be alerted to news on Vindesine News trends on Vindesine
Commentary
Blogs on Vindesine
Definitions
Definitions of Vindesine
Patient Resources / Community
Patient resources on Vindesine Discussion groups on Vindesine Patient Handouts on Vindesine Directions to Hospitals Treating Vindesine Risk calculators and risk factors for Vindesine
Healthcare Provider Resources
Symptoms of Vindesine Causes & Risk Factors for Vindesine Diagnostic studies for Vindesine Treatment of Vindesine
Continuing Medical Education (CME)
CME Programs on Vindesine
International
Vindesine en Espanol Vindesine en Francais
Business
Vindesine in the Marketplace Patents on Vindesine
Experimental / Informatics
List of terms related to Vindesine

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Vindesine is an anti-mitotic vinca alkaloid used in chemotherapy. It is used to treat many different types of cancer, including leukaemia, lymphoma, melanoma, breast cancer, and lung cancer.